Protalix Biotherapeutics Inc (PLX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.23B
EV to revenue ratio (TTM)
2.18
EV to ebitda
6.69
Financial Performance
Revenue (TTM)
$0.08B
Gross profit (TTM)
$0.04B
EBITDA
$0.02B
Profitability
Operating margin (TTM)
23.50%
Profit margin
23.50%
Return on assets (TTM)
15.40%
Return on equity (TTM)
31.20%
Per Share Metrics
Revenue per share (TTM)
$1.01
EPS
$0.24
Diluted EPS (TTM)
$0.24
Book value
$0.60
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
11.92
Trailing P/E
11.92
Forward P/E
51.28
PEG ratio
-0.10
Price to sales ratio (TTM)
2.86
Price to book ratio (TTM)
2.90
Growth
Quarterly earnings growth (YoY)
27.10%
Quarterly revenue growth (YoY)
2,241.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
-0.02